Exchange Announcement • 18 Nov 2024 21:15
Exchange Announcement • 07 Nov 2024 05:30
Exchange Announcement • 06 Nov 2024 20:21
Exchange Announcement • 08 Aug 2024 04:30
Exchange Announcement • 07 Aug 2024 19:15
ENTITY
Aclaris Therapeutics (ACRS US)
Aclaris Therapeutics (ACRS US)
2
Analysis
Health Care • United States
Aclaris Therapeutics, Inc. operates as a clinical-stage specialty pharmaceutical company. The Company focuses on identifying, developing, and commercialization topical drugs to address significant unmet needs in dermatology. Aclaris Therapeutics offers a topical therapy for the treatment of seborrheic keratosis and other verrucoid lesions of the skin.
more
x